Anthropic has acquired a Cambridge biotechnology startup with a single full-time employee, a purchase that signals the company's growing interest in discovering and developing drugs, according to reporting highlighted by WBUR.
Scott Kirsner, a MassLive columnist whose work appears through WBUR's editorial partnership, discussed the acquisition with Morning Edition host Tiziana Dearing. His reporting connects the purchase to Anthropic's deeper interest in the drug-development field.
The acquisition puts a small Cambridge business at the center of that expansion. The available WBUR account identifies the startup's limited staffing but does not provide a purchase price or describe how its work will be incorporated into Anthropic.
The account also does not detail particular drug-development projects or a timetable for work following the acquisition.
